Bergener M, Gola R, Hesse C
Rheinische Landesklinik Köln, Federal Republic of Germany.
Int Psychogeriatr. 1989 Spring;1(1):17-29. doi: 10.1017/s1041610289000037.
Drugs with a short elimination half-life should display fewer side effects than longer acting drugs in the treatment of sleep disturbances due to their smaller tendency to accumulate, especially in the elderly. This hypothesis could be confirmed in a double blind study of zopiclone versus flurazepam.
在治疗睡眠障碍方面,消除半衰期短的药物相较于作用时间长的药物,副作用应更少,因为它们的蓄积倾向较小,在老年人中尤为如此。这一假设在一项佐匹克隆与氟西泮的双盲研究中得到了证实。